{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:34:35Z","timestamp":1788374075600,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020320","name":"Public Health Research Institute","doi-asserted-by":"publisher","award":["IR ESP\/2022\/AL-01"],"award-info":[{"award-number":["IR ESP\/2022\/AL-01"]}],"id":[{"id":"10.13039\/501100020320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jad.2026.121215","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:53:56Z","timestamp":1768838036000},"page":"121215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms"],"prefix":"10.1016","volume":"400","author":[{"given":"Maria","family":"Garcia Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahbia","family":"Belahda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Graux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Serrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9","family":"Igounenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Sergent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Luquiens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121215_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neubiorev.2020.03.017","article-title":"Long-term effects of psychedelic drugs: a systematic review","volume":"113","author":"Aday","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jad.2026.121215_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/adb0000935","article-title":"Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: an interpretive phenomenological analysis","volume":"38","author":"Agin-Liebes","year":"2024","journal-title":"Psychol. Addict. Behav."},{"issue":"12","key":"10.1016\/j.jad.2026.121215_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291724002204","article-title":"Validation of the imperial psychedelic predictor scale","volume":"54","author":"Angyus","year":"2024","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.jad.2026.121215_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.34172\/ahj.2023.1434","article-title":"Prediction of addiction relapse based on perceived social support and childhood trauma","volume":"15","author":"Arabshahi","year":"2023","journal-title":"Addict. Health."},{"key":"10.1016\/j.jad.2026.121215_bb0025","series-title":"StatPearls","article-title":"Defense mechanisms","author":"Bailey","year":"2025"},{"issue":"8","key":"10.1016\/j.jad.2026.121215_bb0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamapsychiatry.2025.0792","article-title":"Symptom provocation and clinical response to transcranial magnetic stimulation: a systematic review and meta-analysis","volume":"82","author":"Bello","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121215_bb0035","series-title":"Adult Rejection Sensitivity Questionnaire (ARSQ) Information, Including the Items, Scoring Interpretation, Permissions, Etc","author":"Berenson","year":"2010"},{"key":"10.1016\/j.jad.2026.121215_bb0040","first-page":"45","article-title":"Aussergew\u00f6hnliche Bewusstseinszust\u00e4nde-Ihre gemeinsame Struktur und Messung [Altered states of consciousness-Their common structure and assessment]","volume":"3","author":"Bodmer","year":"1994","journal-title":"Welten des Bewusstseins. Bd"},{"issue":"1","key":"10.1016\/j.jad.2026.121215_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1556\/2006.7.2018.137","article-title":"Giving room to subjectivity in understanding and assessing problem gambling: a patient-centered approach focused on quality of life","volume":"8","author":"Bonfils","year":"2019","journal-title":"J. Behav. Addict."},{"issue":"10","key":"10.1016\/j.jad.2026.121215_bb0050","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00213-025-06788-w","article-title":"Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs","volume":"242","author":"Borgogna","year":"2025","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.jad.2026.121215_bb0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","article-title":"Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies","volume":"34","author":"Breeksema","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2026.121215_bb0060","first-page":"1","article-title":"Emotion regulation strategies in daily life: mindfulness, cognitive reappraisal and emotion suppression","volume":"46","author":"Brockman","year":"2016","journal-title":"Cogn. Behav. Ther."},{"issue":"3","key":"10.1016\/j.jad.2026.121215_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/02791072.2022.2079108","article-title":"Systematic review of psychometric instruments used in research with psychedelics","volume":"55","author":"de Deus Pontual","year":"2023","journal-title":"J. Psychoactive Drugs"},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2026.121215_bb0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2026.121215_bb0075","series-title":"5D-ABZ: Fragebogen zur Erfassung Aussergewo\u7bd3hnlicher Bewusstseinszusta \u7bd3nde","author":"Dittrich","year":"2006"},{"key":"10.1016\/j.jad.2026.121215_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106776","article-title":"Emotion regulation and experiential avoidance moderate the association between posttraumatic symptoms and alcohol use disorder among Israeli combat veterans","volume":"115","author":"Feingold","year":"2021","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.jad.2026.121215_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchp.2024.100502","article-title":"Emotional dysregulation in relation to substance use and behavioral addictions: findings from five separate meta-analyses","volume":"24","author":"Gonz\u00e1lez-Roz","year":"2024","journal-title":"Int. J. Clin. Health Psychol."},{"issue":"10","key":"10.1016\/j.jad.2026.121215_bb0090","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41386-023-01648-7","article-title":"Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication","volume":"48","author":"Goodwin","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jad.2026.121215_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp.20221043","article-title":"Must psilocybin always \u201cassist psychotherapy\u201d?","volume":"181","author":"Goodwin","year":"2024","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2026.121215_bb0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121215_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119952","article-title":"Mapping psilocybin therapy: a systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials","volume":"391","author":"Kittur","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.jad.2026.121215_bb0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/02698811231158245","article-title":"Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: findings from the Global Drug Survey 2020","volume":"37","author":"Kopra","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jad.2026.121215_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060790","article-title":"Role of patient sex in early recovery from alcohol-related cognitive impairment: women penalized","volume":"8","author":"Luquiens","year":"2019","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.jad.2026.121215_bb0120","doi-asserted-by":"crossref","DOI":"10.2196\/26521","article-title":"Burden and help-seeking behaviors linked to problem gambling and gaming: observational quantitative and qualitative analysis","volume":"8","author":"Luquiens","year":"2021","journal-title":"JMIR Ment. Health"},{"key":"10.1016\/j.jad.2026.121215_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/add.70152","article-title":"Psilocybin in alcohol use disorder and comorbid depressive symptoms: results from a feasibility randomized clinical trial","author":"Luquiens","year":"2025","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.jad.2026.121215_bb0130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1468-5906.2012.01685.x","article-title":"Factor analysis of the mystical experience questionnaire: a study of experiences occasioned by the hallucinogen psilocybin","volume":"51","author":"Maclean","year":"2012","journal-title":"J. Sci. Study Relig."},{"issue":"5","key":"10.1016\/j.jad.2026.121215_bb0135","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1044\/2018_JSLHR-H-18-0370","article-title":"Benefits and shortcomings of direct-to-consumer hearing devices: analysis of large secondary data generated from Amazon customer reviews","volume":"62","author":"Manchaiah","year":"2019","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"6","key":"10.1016\/j.jad.2026.121215_bb0140","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/00952990.2023.2264466","article-title":"Ancient medicine for a modern disease: traditional Amazonian medicine to treat substance use disorders","volume":"49","author":"Mendive","year":"2023","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.jad.2026.121215_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106163","article-title":"Efficacy and safety of psilocybin for the treatment of substance use disorders: a systematic review","volume":"173","author":"Meshkat","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.jad.2026.121215_bb0150","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1177\/00048674251346679","article-title":"Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers","volume":"59","author":"Nadeem","year":"2025","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121215_bb0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2018.00132","article-title":"The psychedelic debriefing in alcohol dependence treatment: illustrating key change phenomena through qualitative content analysis of clinical sessions","volume":"9","author":"Nielson","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2026.121215_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107592","article-title":"Validating the primary care posttraumatic stress disorder screen for DSM-5 (PC-PTSD-5) in a substance misusing, trauma-exposed, socioeconomically vulnerable population","volume":"139","author":"Patton","year":"2023","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jad.2026.121215_bb0165","series-title":"\u00abIRAMUTEQ\u202f: impl\u00e9mentation de la m\u00e9thode ALCESTE d\u2019analyse de texte dans un logiciel libre\u00bb Mod\u00e9lisation Appliqu\u00e9es aux Sciences Humaines et Sociales (MASHS 20009)","author":"Ratinaud","year":"2009"},{"key":"10.1016\/j.jad.2026.121215_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103149","article-title":"Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial","volume":"82","author":"Rieser","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jad.2026.121215_bb0175","series-title":"Predicting Depression in Screening Interviews From Latent Categorization of Interview Prompts","author":"Rinaldi","year":"2020"},{"key":"10.1016\/j.jad.2026.121215_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106086","article-title":"The intensity of the psychedelic experience is reliably associated with clinical improvements: a systematic review and meta-analysis","volume":"172","author":"Romeo","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.121215_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.jad.2026.121215_bb0190","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: validation of the Emotional Breakthrough Inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2026.121215_bb0195","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/acsptsci.1c00097","article-title":"Moving past mysticism in psychedelic science","volume":"4","author":"Sanders","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jad.2026.121215_bb0200","series-title":"Mindfulness-based Cognitive Therapy for Depression","author":"Segal","year":"2012"},{"issue":"1","key":"10.1016\/j.jad.2026.121215_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0376-8716(96)01263-X","article-title":"The reliability of the Alcohol Timeline Followback when administered by telephone and by computer","volume":"42","author":"Sobell","year":"1996","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2026.121215_bb0210","first-page":"1","article-title":"Suggestion effects in psychedelics: confounds and opportunities","author":"Stein","year":"2025","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"10.1016\/j.jad.2026.121215_bb0215","series-title":"Classifying Non-banking Monetary Systems Using Web Data","author":"Tichit","year":"2015"},{"key":"10.1016\/j.jad.2026.121215_bb0220","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2147\/NDT.S104442","article-title":"Measuring illness insight in patients with alcohol-related cognitive dysfunction using the Q8 questionnaire: a validation study","volume":"12","author":"Walvoort","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2026.121215_bb0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/02698811211073758","article-title":"The Acceptance\/Avoidance-Promoting Experiences Questionnaire (APEQ): a theory-based approach to psychedelic drugs\u2019 effects on psychological flexibility","volume":"36","author":"Wolff","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121215_bb0230","doi-asserted-by":"crossref","DOI":"10.1177\/02698811241249698","article-title":"Measuring psychotherapeutic processes in the context of psychedelic experiences: validation of the General Change Mechanisms Questionnaire (GCMQ)","volume":"38","author":"Wolff","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2026.121215_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79931-w","article-title":"Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study","volume":"14","author":"Wood","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:22:51Z","timestamp":1781943771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"alternative-id":["S0165032726000662"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121215","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121215"}}